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Abstract: Introduction: Blunted, inappropriate affective-social behavior is a hallmark of early schizo-
phrenia, possibly corresponding to reduced ability to recognize and express emotions. It is yet
unknown if this affective deficiency relates to disturbed neural sensitivity to facial expressions or to
overall face processing. In a previous imaging study, healthy subjects showed less suppression of the
fusiform gyrus (FG) to repeated presentation of the same transfigured-bizarre face relative to regular
face. We assumed that the FG in schizophrenia will show reduced repetition related sensitivity to
transfigured-bizarre faces, while having overall normal response to faces. Methods: Ten first-episode
patients with schizophrenia and 10 controls rated the bizarreness of upright and inverted faces. In an
fMRI study, another group of 17 first-episode patients with schizophrenia and 12 controls viewed regu-
lar and transfigured-bizarre faces in blocks. Each block contained regular- or transfigured-bizarre faces
of either different or same individual, presented in an upright or inverted orientation. Results: Patients
in comparison with controls rated irregular faces as less bizarre. The FG, in patients and controls exhib-
ited similar response to inverted faces, suggesting normal face processing. In contrast, the FG only in
patients, showed similar suppression to repeated transfigured-bizarre and regular faces. Finally, the FG
in patients compared with controls showed reduced functional connectivity with the amygdala and
prefrontal cortex. Conclusion: Patients with schizophrenia already at first-episode, showed reduced be-
havioral and neural sensitivity to bizarre facial expressions. Possibly, this deficiency is related to dis-
turbed modulations of emotion-related face processing in the FG by the amygdala and prefrontal cor-
tex. Hum Brain Mapp 00:000–000, 2009. VC 2009 Wiley-Liss, Inc.
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INTRODUCTION
Patients with schizophrenia often manifest deficient
emotional behavior, expressed as blunted or inappropriate
affective response in a social context [Flaum and Schultz,
1996]. One possible link between social and emotional
behavior could be related to sensitivity to adequacy of fa-
cial expressions. Patients with schizophrenia indeed suffer
from a markedly reduced ability to recognize and express
face-related emotions [Addington and Addington, 1998;
Gessler et al., 1989; Mandal et al., 1998]. It remains unclear
whether this abnormality is related to deficient processing
of faces per se or of their emotional expressions. Sorting
out these aspects of face processing is especially difficult
since they tend to interact [Calder et al., 2000]. This was
recently demonstrated by a study showing that healthy
controls had a greater accuracy in emotional detection for
upright than inverted orientation of faces [Fallshore and
Bartholow, 2003]. Intriguingly, perception of facial expres-
sion in schizophrenia was shown to be less affected by
face inversion, suggesting that patients may use different
strategies to decode emotional information from faces
[Chambon et al., 2006].
Neural representations of facial processing have been
extensively investigated by modern brain imaging techni-
ques. The fusiform gyrus (FG) was verified as one of the
major areas for face processing in the human healthy
brain, showing selective response to faces compared with
other objects [Kanwisher et al., 1997]. It was also shown
that the FG is modulated by inverted orientation [Yovel
and Kanwisher, 2004] and negative emotional content
[Bleich-Cohen et al., 2006] of faces.
One way to study the sensitivity of a region for a stimu-
lus’ parameter is by looking if it modifies the amount of
activation suppression to repeated presentation of the
stimulus (i.e., repetition-suppression effect). This approach
has been widely implemented in studying high-order vis-
ual processing including features of faces [Grill-Spector
et al., 1999, 2006]. To study whether facial expressions
modulate the repetition-suppression effect one needs to
keep all other face-related features unchanged. In a previ-
ous fMRI study in our lab with healthy subjects, we sepa-
rated between these parameters by applying the ‘‘Thatcher
illusion,’’ where face content is transfigured from regular
to bizarre while keeping its local features largely
unchanged [Thompson, 1980]. This previous fMRI study
showed that ‘‘repetition-suppression’’ effect was dimin-
ished when facial expression were transfigured and rated
as bizarre and unpleasant. Furthermore, greater inter-re-
gional correlation between amygdala and FG to transfig-
ured-bizarre faces, supported enhanced local cooperative
computation of a ‘‘far-from-template’’ facial expression
[Hendler et al., 2003; Rotshtein et al., 2001]. It can therefore
be presumed that the degree of reduced selectivity of the
repetition-suppression effect in the FG marks its sensitivity
to facial content. Activation selectivity of the FG to emo-
tional content could be mostly related to its modulation by
other brain regions such as the amygdala. Indeed the FG has
extensive reciprocal connections with the amygdala [Amaral
et al., 2003] and the prefrontal cortex (BA 10,11) [PFC; Rolls,
1999a,b], both implicated in emotion processing of faces
[Hasselmo et al., 1989; Krolak-Salmon et al., 2004].
In terms of schizophrenia there is disagreement on the
effectiveness of face-related neural processing in the FG.
Several studies showed a reduction in the overall response
of the FG to faces in schizophrenia compared with healthy
controls [Gur et al., 2002; Johnston et al., 2005; Yoo et al.,
2005]. These findings are further supported by anatomical
evidence of reduced volume of the FG in patients with
schizophrenia [Ha et al., 2004; Lee et al., 2002; McDonald
et al., 2000; Onitsuka et al., 2003, 2004, 2005; Pantelis et al.,
2003]. Others argued that after controlling for individual
anatomical differences, task difficulty and variability in the
hemodynamic response, FG responses to faces in schizo-
phrenia do not differ from healthy controls [Yoon et al.,
2006]. Moreover, there is no agreement whether schizo-
phrenia alters selective responses of the FG to the emo-
tional content of faces [Phillips et al., 1999].
The overall goal of this study was to sort out whether
patients with first episode schizophrenia suffer from
abnormal neural processing of faces per se or of their
emotional content. More specifically, behavior wise, we
aimed to test the sensitivity to facial bizarreness in
patients with schizophrenia relative to healthy controls.
To manipulate facial expressions while keeping local fa-
cial features unchanged we applied the Thatcher’s illu-
sion procedure [see Rotshtein et al., 2001]. To test brain-
related abnormalities in schizophrenia, we applied fMRI
on another group of patients. The sensitivity of the FG to
irregularities in facial expressions was tested by selectiv-
ity of repetition-suppression effect to regular and transfig-
ured-bizarre facial expressions. We predicted that
patients with schizophrenia compared with healthy con-
trols will show diminished behavioral sensitivity to ET
faces. Accordingly, it was also expected that patients will
show reduced sensitivity of the FG to repeated presenta-
tion of bizarre faces along-side with overall normal
response to face inversion.
MATERIALS AND METHODS
Experiment 1: Behavioral Sensitivity
to Bizarre Facial Expression
Subjects
Ten right-handed patients with schizophrenia (age 5
22–33 yrs; 7 men), first-episode of psychosis, hospitalized
<1 month at the Beer Yaakov Mental Health Center were
enrolled. They were either nonmedicated or medicated for
<1 month with antipsychotic drugs with a rating on the
Clinical General Impression (CGI) scale of 4–5. Psychia-
trists verified patients’ schizophrenia diagnoses according
to DSM-IV criteria. None had prior history of neurological
r Bleich-Cohen et al. r
r 2 r
and substance abuse disorders based on physical and neu-
rological examination, routine laboratory investigation and
medical records. Ten right-handed matched controls par-
ticipated (age 5 24–31 yrs; 5 men) as a control group and
were interviewed by a psychiatrist to exclude major neuro-
logical and psychiatric disorder. Before study entry, all
participants provided written informed consent that was
approved by the Beer Yaakov Mental Health Center Insti-
tutional Review Board.
Stimuli and task
The original visual stimuli consisted of 40 achromatic
close-up photographs of faces presented in front view with
a red fixation point added in the center of the image. The
expressional transfiguration (ET) was obtained by 1808
rotation of the eyes and the mouth of the regular face (Fig.
1a). Each face type was presented in upright and inverted
orientations. Participants were requested to rate the
bizarreness of each face on a scale of 1–5 (1 5 ‘‘most bi-
zarre,’’ 5 5 ‘‘least bizarre’’). Stimuli were presented ran-
domly for 0.9 s followed by a blank screen until the sub-
jects responded. Presentation software (Neurobehavioral
Systems, Inc., 2003) was used to present stimulus and re-
cord subjects’ responses and the STATISTICA (version 5.0)
software was used to analyze the data.
Results and discussion
Three-way analysis of variance (ANOVA) (group 3 ori-
entation 3 expression) for repeated measures was pre-
formed with orientation condition (upright/inverted) and
expression (regular/ET) as factors within group and diag-
nosis (schizophrenia/healthy) as a between-group factor.
We found that ET faces were judged as more bizarre than
regular faces [main effect of expression, F(1,19) 5 87.56; P
< 0.00001, Fig. 2], and that this effect was mostly pro-
nounced in the upright orientation [Interaction of orienta-
tion and expression (F(1, 19) 5 37.705, p 5 .00001)]. This
replicates numerous previous studies that tested for the
effect of bizarreness on face perception [Rotshtein et al.,
2001; Thompson, 1980].
The patients, but not the controls, rated all face types as
less bizarre [main effect of group, F(1,19) 5 10.76; P <
0.005) and this effect was more pronounced for the ET
faces [two-way interaction of group by expression, F(1,19)
Figure 1.
Stimulus types and experimental design. (a) Example of face
types: regular and ET expressions, and upright and inverted ori-
entations (b) Repetition manipulation was done in blocks: each
face type was presented in blocks of repeated or different pre-
sentations.
Figure 2.
Behavioral results of bizarreness ratings in patients with schizophrenia and healthy controls for
regular and ET expressions in upright (a) and inverted (b) orientations. Error bars represent
standard error of the mean (SEM).
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5 11.39; P < 0.005]. Post-hoc analysis revealed that ET
faces in both upright and inverted orientation were judged
as less bizarre by the patients in comparison with the
healthy controls (Tukey HSD post hoc P < 0.0005). This
result concurs with the hypothesis that schizophrenia
attenuates the ability to properly evaluate the meaning of
irregularities within perceptual information. Thus, ET faces
were perceived more normal-like by patients than by
healthy controls.
Experiment 2: Neural Sensitivity
to Bizarre Facial Expression
Subjects
Additional group of patients with schizophrenia and
controls participated in the fMRI session. The study popu-
lation consisted of 19 right-handed patients with schizo-
phrenia (age 5 21–35 yrs; 11 men) in their first episode of
psychosis, all hospitalized for the first time at the Beer
Yaakov Mental Health Center. The clinical evaluation pro-
cedure was similar to that of the behavioral study. Because
of extensive head movements (head movement > 1.5 mm),
two patients were excluded from the final analysis.
Patients were either nonmedicated or medicated for <1
month (Table I). We obtained a measure of each schizo-
phrenia patient’s symptoms based on the Positive and
Negative Syndrome Scale (PANSS) [Kay et al., 1987] and
the CGI-S [Guy, 1976] (single rater RDS). Twelve age- and
gender-matched right-handed healthy volunteers (age 5
25–54 years; 7 men) were recruited as controls. All healthy
subjects were interviewed by a senior psychiatrist to
exclude any major neurological and psychiatric disorder.
Before study entry, all subjects provided written informed
consent that was approved by the Beer Yaakov Mental
Health Center Institutional and the Tel Aviv Sourasky
Medical Center review boards.
Visual stimuli
The baseline visual stimuli consisted of the same stimuli
described in experiment 1 (Fig. 1a). The regular and ET
faces, turned upside down, created the conditions of the
inverted-regular and the inverted ET faces. Four of the
faces, used in the repeated presentation conditions (see
below), had an additional version in which their overall
contrast level was reduced by 15% because of task require-
ments (see below). This was not expected to affect activa-
tion in high-order visual areas [Avidan et al., 2002].
fMRI experimental procedure
Visual stimuli were presented in a block design fashion.
Epochs consisted of either different-faces (Diff) or
repeated-face (Rep) conditions. In the Rep condition, the
same face was presented 15 times, whereas in the Diff con-
dition, 15 different faces from the same type were pre-
sented (Fig. 1b). The epochs were separated by 6–9 s in
which subjects viewed a fixation point on a gray back-
ground. Each condition was presented two to four times
within each scan session, in a design that balanced for the
order of conditions. Stimuli presentation rate was 1 Hz
(0.9 s a face interposed with 0.1 s blank). A 100 ms blank
of mean luminance interposed between consecutive images
to match the interimage transients in all blocks. The stim-
uli sequences were generated on PC and projected via an
LCD projector (Epson MP 7200) onto a translucent tangent
screen located on the head coil in front of the subject’s
forehead. Subjects viewed the screen through a tilted mir-
ror fixed to the head coil. To equally engage the observer’s
TABLE I. Demographic and clinical data of schizophrenia patients












1 32 F 18 29 31 78 4 2 No
2 25 M 20 14 37 71 5 3 No
3 23 M 23 18 36 81 4 3 No
4 27 F 25 18 38 81 5 3 Risperidone (14 days)
5 35 M 17 15 23 55 3 5 No
6 24 M 30 20 41 91 5 7 No
7 27 F 24 22 28 74 5 9 Risperidone (7 days)
8 36 F 22 11 32 65 4 9 Clothiapine (7 days)
9 29 F 31 27 42 100 5 12 Risperidone (2 days)
10 30 M 21 17 30 68 4 14 Risperidone (11 days)
11 34 F 13 23 34 70 4 16 Clopixol (14 days)
12 24 M 26 16 34 76 4 17 Zuclopenthixol (2 weeks)
13 21 M 30 14 29 73 4 25 Zuclopenthixol (3 weeks)
14 21 F 12 19 48 79 4 28 Perphenazine (7 days)
15 21 M 28 21 35 84 5 28 Quetiapine (2 weeks)
16 34 F 25 17 34 76 5 35 Olanzapine (28 days)
17 28 M 32 21 33 86 5 56 Risperidone (28 days)
PANSS, Positive and Negative Symptom Scale; CGI, Clinical Global Impression.
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attention across ET and regular face conditions, subjects
were asked to fixate on the red point and to perform a
covert one-back-matching task through the whole run.
They were instructed to indicate whether or not two suc-
cessive faces were identical. In the Rep conditions, the dif-
ference was related to the contrast of the stimuli, whereas
in the Diff conditions, the difference was related to iden-
tity of faces. In each epoch, three to four (of 15) stimuli
created these differences. In the Rep condition, one image
differed in its overall contrast (15%)—we encourage the
reader to identify it, so as to appreciate the task difficulty
involved.
MRI set-up
Imaging was performed on GE 1.5T Signa Horizon LX
8.25 echo speed scanner (Milawaukee, W1) with resonant
gradient echoplanar imaging system. All images were
acquired using a standard quadrature head coil. The scan-
ning session included anatomical and functional imaging.
The anatomical images were high resolution sagital local-
izer acquired in the beginning of each scanning session.
Seventeen contiguous axial T1-weighted slices of 4-mm
thickness, 1-mm gap were prescribed, based on the sagital
localizer, covering the whole brain except the most dorsal
and ventral tips. In addition, a 3D spoiled gradient echo
(SPGR) sequence, with high resolution, was acquired for
each subject, to allow volume statistical analyses of signal
changes during the experiment. Functional T2*-weighted
images were acquired (at the same locations as the spin-
echo T1-weighted anatomical images), in runs of 2856–
2890 images (168–170 images per slice). fMRI acquisition
parameters were as follows: TR/TE/flip angle 5 3000/55/
908; with FOV 24 3 24 cm2 matrix size 80 3 80.
Data analysis
fMRI data were processed using BrainVoyager4.4 and
QX1.8 software package [Goebel et al., 1998a,b] (http://
www.brainvoyager.com). Comparison of the raw func-
tional data with the two-dimensional (2D) structural scan
enabled an estimate of the extent of signal dropout attrib-
utable to a susceptibility artifact for each subject. Func-
tional images were incorporated into the three-dimensional
(3D) data sets through trilinear interpolation. The complete
data set was transformed into Talairach space [Talairach
and Tournoux, 1988]. Preprocessing of functional scans
included head movement assessment (scans with head
movement > 1.5 mm were rejected), high-frequency tem-
poral filtering, and removal of low-frequency linear trends.
Three-dimensional statistical parametric maps were calcu-
lated separately for each subject using a general linear
model (GLM) [Friston et al., 1995] in which all stimuli con-
ditions were positive predictors, with a lag of 3–6 s (to
account for the hemodynamic response delay). In addition,
the first six images of each functional scan were rejected to
allow for T2* equilibration effects.
Regions of interest analysis in the fusiform gyrus
Based on our a-priori hypothesis, we focused our analy-
sis on the fusiform gyrus. The definition of the regions of
interest (ROI) was done based on anatomical constraints of
previously reported functional foci in the fusiform gyrus
[i.e., Talaraich coordinates: left fusiform gyrus: 236 6 3,
253 6 3, 216 6 4; right fusiform gyrus: 36 6 3, 253 6 3,
216 6 4; see Rotshtein et al., 2001]. We then extracted
from each individual an averaged time course obtained
across voxels that showed larger responses to faces than to
fixation within these anatomical regions (P < 0.005 uncor-
rected). Significance tests were performed on the average
percent signal change for each condition per group. Four-
way ANOVAs for repeated measures were preformed
with orientation condition (upright/inverted), expression
(regular/ET), and repetition (repeated/different) as factors
within group and diagnosis (schizophrenia/healthy) as a
between-group factor. For each face type, repetition-sup-
pression ratio was calculated by dividing the repeated con-
dition by its corresponding different condition. A ratio of 1
indicated no suppression. Finally, we analyzed the activa-
tion in the fusiform gyrus based on the symptoms exhib-
ited by the patients, as obtained from the clinical assess-
ment. In this analysis, we divided the subjects into two
groups in accordance to the median of several parameters
of the clinical symptoms, such as positive, negative, gen-
eral and total symptoms, clinical global impression (CGI),
medication, age, length of hospitalization, and gender (see
Table I). We then tested the correlation between these clin-
ical measurements and the responses we observed in each
patient’s fusiform gyrus.
Whole brain analysis
Using random effect models, we compared brain
responses of healthy controls and patients with schizophre-
nia to test for any significant differences that were outside
our a-priori ROIs. We compared responses with face versus
fixation, ET versus regular faces, upright versus inverted
faces, and responses to different versus repeated condition
at threshold of P< 0.005 with random effect.
Correlation map analysis
We applied interregional correlation analysis using time
courses obtained from the left and right fusiform gyri
[Friston et al., 1993, 1995]. The ‘‘seed region’’ was anatomi-
cally defined based on our a-priori ROI in the fusiform gyrus
in each cortical hemisphere. Time courses were obtained
individually from a 20-voxel cluster in the fusiform area that
showed the most significant repetition-suppression effect for
ET faces (note that although the overall suppression effect
for ET faces was small in the healthy group, it yet existed at a
sub-cluster of voxels within the fusiform gyrus). The average
time course was used as a predictor in GLM to compute a
voxel-by-voxel fit. A second-level random-effect based
group analysis with FDR of 0.0001 was applied to determine
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the brain areas that showed significant functional connectiv-
ity with the fusiform gyrus across subjects. This second level
analysis revealed significant activation in the amygdala and
PFC of the healthy controls in comparison with the patients.
Thus, we quantified the between-group differences in the
amygdala and PFC (BA 10, 11) by counting the number of
activated voxels in each subject in these two brain regions
and performed a Mann-Whitney U test on the number of
voxels in the bilateral amygdala and PFC between the two
groups.
Results of Experiment 2
ROI analysis in the fusiform gyrus
A four-way ANOVA (group 3 orientation 3 repetition
3 expression) was preformed with group (schizophrenia/
healthy) as a between factor and orientation (upright/
inverted), repetition (repeated/different), and expression
(regular/ET) as within factors. Both groups demonstrated
more activation for ET than for regular faces [main effect
Figure 3.
Repetition-suppression effect in the fusiform gyrus: Overlay time-courses and calculated ratio (right
column) of averaged percent signal change for different (bold line) and repeated (thin line) presenta-
tions of faces with regular and ET expressions, presented for the healthy controls (a) and patients
with schizophrenia (b) groups. Error bars represent standard error of the mean (SEM).
Figure 4.
Selective response of the FG to ET faces in relation to symptom
severity measures by the PANSS. (a) Averaged percent signal
changes in response to faces with regular and ET expressions for
schizophrenia subgroups categorized by the general PNASS scale
(>34 5 gray, <34 5 stripes). (b) Correlation between score on
the general PNASS scale and the FG selective activation for ETrel-
ative to regular upright faces. The value of 1 means no selectivity.
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for expression, F(1,27) 5 9.554; P < 0.005], more activation
for upright than inverted faces [main effect for orientation,
F(1,27) 5 10.388; P < 0.005], and more activation for the
different than repeated faces [main effect of repetition,
F(1,27) 5 24.704; P < 0.0001]. A three-way interaction
[group 3 repetition 3 expression, F(1,27) 5 4.475; P <
0.05] revealed that the groups differed significantly on
effect of face content on repetition-suppression. Figure 3
displays this interaction effect via averaged time courses
for repeated and different presentations (thin and bold
lines respectively), per group [healthy (Fig. 3a) and schizo-
phrenia (Fig. 3b)], and face type (regular and ET faces, the
first and second columns, respectively). Post-hoc analysis
revealed that there was a significant suppression effect for
the ET faces only for the patients (Tukey LSD post hoc P
< 0.05). To further demonstrate this interaction between
face type and repetition, we calculated an averaged repeti-
tion-suppression ratio (see Methods section) for each
group (Fig. 3a,b right column).
It’s important to note that we conducted the same analy-
sis without the older subject (age 5 54) in the healthy
group and still received the same significant effects and
interactions. Therefore we did not exclude him. To explore
the effect of symptoms on the fusiform activation we di-
vided the patients into two subgroups; below and above
the median (e.g. 34). This division based on scoring of the
general PNASS scale revealed significant interaction of
group by face type for fusiform activation for all face pre-
sentation [group 3 expression, F(1,14) 5 5.35; P < 0.05].
There was difference in the FG activation between the
groups that was greater for ET faces than for regular faces
(Tukey HSD post hoc P < .001; Fig. 4a). Similarly the
PNASS general scale scoring was negatively correlated
with the difference in fusiform activation between ET and
regular faces (r 5 20.51, P < 0.05, Fig. 4b).
Whole brain analysis
We performed a whole brain analysis to test for any sig-
nificant group differences that were outside our a-priori
ROIs. The contrast of ET versus regular faces for the
repeated condition revealed a different set of regions for
each group. Healthy controls but not patients with schizo-
phrenia had greater activation for ET than regular faces in
the fusiform gyrus, lateral occipital cortex, middle tempo-
ral gyrus, precentral gyrus (BA 6), middle frontal gyrus
(BA 9/10), lentiform nucleus, putamen, and amygdala (Ta-
ble II). Figure 5 shows an overlay of activation maps
obtained for each group for all face conditions versus fixa-
tion (group GLM, random effect, FDR P < 0.01). This over-
lay map reveals that although the healthy and patients
with schizophrenia activated the visual areas with consid-
erable overlap (purple color), the amygdala (white circle)
was more active by the healthy controls (red color) than
the schizophrenia group (blue color).
Whole brain voxel-based correlation with the fusiform
time-course revealed considerable difference in the spatial
extent of coactivations between the two groups. Overlay
maps of the correlation maps obtained from each group
shows that although both groups equally correlated in pos-
terior regions with the fusiform gyrus, the patients with
schizophrenia showed reduced correlation of the fusiform
gyrus with the amygdala and PFC (see Fig. 6). Table III
presents the regions that were coactivated with the fusi-
Figure 5.
Whole brain activation for all faces versus blank (FDR of 0.01,
random effect for each group), shown as an overlay-map of 11
healthy controls (red), 17 patients with schizophrenia (blue), and
both (purple). White circle marks the amygdala nucleus obtained
only for the healthy group.
TABLE II. Interaction between ET faces and repeated condition for controls
Region of interest Left Peak P Right Peak P
Fusiform gyrus 39, 250, 212 0.0028
Lateral occipital 242, 265, 28 0.0192 49, 268, 26 0.0058
Middle temporal gyrus 258, 1, 213 0.0011
Precentral gyrus (BA 6) 51, 22, 31 0.0098
Middle frontal gyrus (BA 9/10) 231, 41, 23 0.0075
Lentiform nucleus, putamen 24, 9, 4 0.0070
Amygdala 221, 27, 213 0.0013 22, 27, 217 0.0012
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form gyrus. Healthy controls but not the patients with
schizophrenia demonstrated correlated activation in limbic
areas, ventral prefrontal regions and the STS. We quanti-
fied the between-group differences in the amygdala and
PFC (BA 11) by counting the number of correlated voxels.
This analysis revealed significant decrease in the number
of correlated voxels in patients with schizophrenia com-
pared with healthy controls in bilateral PFC (BA 11) and
bilateral amygdala. The P values for these comparisons
calculated by Mann-Whitney U test are summarized in
Table IV. It is worth noting that there was no significant
correlation between symptom severities scales (PANSS
Figure 6.
Functional connectivity maps revealed by
an averaged time-courses from right and
left FG for upright ET faces in different ver-
sus repeated presentations (random effect,
FDR of 0.0001). Overlay maps of functional
connectivity are shown in sagital and coro-
nal views for 12 healthy controls (red), 17
patients with schizophrenia (blue), and
both (purple) groups. The arrows point to
the PFC (BA 10, 11) and the amygdala
where correlated activation with the FG
was found for healthy controls but not for
patients with schizophrenia.
TABLE III. Functional connectivity with activation in the fusiform gyrus
ROI Left AvgPValue t-score Right AvgPValue t-score
A. Healthy controls
PFC (BA 6) 235, 29, 42 0.1 3 1020.8 6.21 47, 24, 41 0.1 3 1020.8 6.22
PFC (BA 8) 245, 8, 34 0.1 3 1020.8 6.79 43, 8, 34 0.1 3 1020.8 6.43
PFC (BA 9/46) 241, 30, 33 0.6 3 1020.5 4.94 39, 34, 35 0.6 3 1020.5 4.76
PFC (BA 10) 218, 47, 26 0.7 3 1020.5 4.72 21, 47, 26 0.7 3 1020.5 4.89
PFC (BA 11) 218, 48, 28 0.2 3 1020.8 5.04 23, 47, 28 0.8 3 1020.5 4.63
Intraparietal sulcus 224, 259, 56 0.2 3 1020.8 6.83 32, 258, 55 0.1 3 1020.8 6.82
STS 255, 237, 17 0.7 3 1020.5 4.68 50, 242, 19 0.6 3 1020.5 4.89
Amygdala 215, 26, 214 0.1 3 1020.8 7.12 25, 24, 212 0.1 3 1020.8 6.63
Insula 231, 23, 9 0.1 3 1020.8 7.52 33, 21, 9 0.1 3 1020.8 7.03
Thalamus 29, 220, 3 0.1 3 1020.8 6.48 5, 219, 4 0.1 3 1020.8 6.81
Head of Caudate 210, 16, 10 0.1 3 1020.8 6.80 13, 17, 10 0.1 3 1020.8 6.55
Lentiform 21, 8, 7 0.1 3 1020.8 6.91
B. Schizophrenia patients
PFC (BA 6) 235, 211, 32 0.1 3 1020.8 7.03 47, 3, 41 0.1 3 1020.8 7.03
PFC (BA 8) 237, 4, 34 0.1 3 1020.8 6.12 44, 4, 34 0.1 3 1020.7 6.23
PFC (BA 9/46) 235, 33, 33 0.1 3 1020.8 6.22 41, 34, 33 0.1 3 1020.7 6.13
Intraparietal sulcus 225, 259, 50 0.1 3 1020.8 6.58 33, 266, 51 0.1 3 1020.8 6.36
Insula 231, 19, 9 0.1 3 1020.8 6.57 34, 20, 9 0.1 3 1020.8 6.42
Thalamus 29, 218, 3 0.1 3 1020.8 6.26 9, 219, 3 0.1 3 1020.8 6.62
Lentiform 223, 4, 7 0.1 3 1020.8 6.38
PFC, prefrontal cortex; STS, superior temporal sulcus.
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positive, negative, and general scores) and numbers of cor-
related voxels in the PFC and amygdala.
DISCUSSION
The behavioral findings demonstrate that patients with
schizophrenia already in their first episode suffer from
reduced ability to detect bizarreness in faces. This seems to
correspond to diminished neural sensitivity in the FG to
repeated presentation of irregular facial expressions (e.g.
ET). Unlike in healthy controls, the FG in patients with
schizophrenia presented the same magnitude of suppression
to both the repeated regular faces and bizarre ET faces. This
abnormality correlated with the individual symptom sever-
ity according to general PANSS. Interestingly, the overall
effect of repetition and inverted orientation of faces in the
FG was similar in controls and patients with schizophrenia,
suggesting normal face processing. Functional connectivity
analysis supported the notion that disturbed interaction
between the FG, amygdale, and the PFC (BA 10, 11) in
patients with schizophrenia might contribute to the
decreased neural sensitivity to bizarreness in faces.
In terms of the magnitude of visual activation it is worth
noting that compared with healthy controls, patients with
schizophrenia had less overall visual activation in the FG
(see Fig. 3). This could be related to general effects of
arousal possibly because of drug effect. To preclude drug
treatment effect on the magnitude of activation in the vis-
ual cortex, we compared between patients with and with-
out medication and found no difference. Interestingly,
Miller et al. [1997] demonstrated that patients treated with
antipsychotic drugs had significantly higher regional cere-
bral blood flow in the left FG compared with the 3 weeks
off-medication condition. Indeed most of our patients
received antipsychotic drug treatment for <4 weeks, a rela-
tively short time for these drugs to be efficacious.
Reduced Face-Related Content Sensitivity
in the Fusiform Gyrus
The content-related diminished effect of repetition-sup-
pression in the FG of our healthy controls corresponds to our
previous finding with the similar paradigm [Rotshtein et al.,
2001]. The attenuation of this expressional modulation in
patients with schizophrenia might contribute to low behav-
ioral sensitivity to value bizarreness in facial expression.
The repetition-suppression effect in sensory brain
regions is believed to reflect enhanced selectivity to a stim-
ulus, possibly by reducing the recruitment of neurons
upon its repeated presentation [Grill-Spector et al., 1999].
When considering the FG and its selectivity to faces, one
can think of the repetition-suppression effect in terms of
neural sensitivity to irregularities in the selective stimulus
of this area (i.e., face). Accordingly, it is claimed that in
our study patients with schizophrenia showed reduced
sensitivity of the FG to irregular shape in the faces result-
ing in bizarre expressions. Since the bizarreness of ET
faces was shown to correlate with unpleasantness [Rotsh-
tein et al., 2001], it is impossible to sort out whether this
content effect is related to irregularity and inadequacy (i.e.,
bizarreness) or negative valence of the ET faces. Support
for the later comes from prior neuroimaging studies that
demonstrated an emotional deficit in face processing by
presenting less FG activation in response to faces in
chronic schizophrenia patients than in healthy controls.
For example, Taylor et al. [2002] showed that chronic
schizophrenia patients in comparison with healthy controls
had significantly less selective activation in the FG for neg-
ative relative to neutral content in pictures. Similarly,
Fakra et al. [2008] presented decreased activation in the FG
in chronic schizophrenia patients during a matching task
of emotional faces in comparison with controls.
Does abnormal emotional processing in faces mark defi-
cient social cognition in schizophrenia? Rating ET faces as
relatively not-bizarre can be interpreted as a poor mecha-
nism for assigning adequate social value for stimuli in the
environment. This in turn might lead to inappropriate social
behavior, a hallmark sign of acute schizophrenia. Intriguingly,
the abnormality in the FG activation was unrelated to the se-
verity of positive or negative symptoms as measured by the
PNASS. Rather it was related to the score of general PNASS
reflecting a decline in everyday functions such as interperso-
nal interaction and social behavior. Accordingly, our data
indicate that the reduced sensitivity of the FG to ET faces was
mainly contributed by the group of patients with the highest
score on the general scale of the PANSS (see Fig. 4).
Reduced Face-Related Coactivation
With the Fusiform Gyrus
Studies in primates have shown extensive reciprocal
connections between the FG and the amygdala [Amaral
et al., 2003], which is implicated in emotion processing of
faces [Hasselmo et al., 1989; Krolak-Salmon et al., 2004;
Morris et al., 1996, 1998]. In our study, we found both
reduced overall activity of the amygdala (see Fig. 5) and
weaker functional connectivity of the amygdala with the
FG (see Fig. 6) in the patients compared with healthy con-
trols. Our finding of increased left amygdala activation to
all face contrast in the healthy controls is in agreement
with the leading findings in the literature regarding later-
alization of the amygdala [Baas et al., 2004; Fitzgerald
et al., 2006]. Previous imaging studies showed reduced
activation in the amygdala in patients with schizophrenia
for sad mood induction [Schneider et al., 1998] and during
a discriminative emotional valance task of faces [Gur et al.,
TABLE IV. Significance of the between-group
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2002]. Here, we demonstrate that the amygdala is overall
hypoactive to faces even when the task is irrelevant to
emotion, pointing to a more general role of the amygdala
in assigning value to a face through its social content. This
idea is supported by recent finding from fMRI study in
monkeys showing that the amygdala nuclei are sensitive
to social content in faces [Hoffman et al., 2007]. The cur-
rent finding of diminished connectivity between the amyg-
dala and FG in schizophrenia, uniquely point to a possible
role of the amygdale in contributing to the reduced sensi-
tivity of the FG to face-related content in patients.
Another region that clearly showed reduced functional
connectivity with the FG in schizophrenia is the PFC (BA
10,11). This area is known to receive dense inputs from
several processing levels in the visual cortex [Rolls,
1999a,b]. The relevance of these areas to emotional proc-
essing is suggested by the evidence of dense reciprocal
connections between the PFC and the amygdala. More-
over, damage to the ventral PFC is known to cause major
deficits in social and emotional behavior in humans. For
example, it was shown that patients with lesions in the
PFC are impaired in face and voice expression identifica-
tion [Hornak et al., 2003]. Structurally disorganized pre-
frontal but not parietal fiber tracking in first episode schiz-
ophrenia further supports the possibility that the reduced
functional connectivity in the current study is related to
deficient modulation of the FG by the prefrontal cortex
[Mendelsohn et al., 2006]. Further studies are needed to
sort this causal relation.
Our finding regarding the relation between PFC and the
FG echo with the idea that disturbed long-distance connec-
tions between frontal and posterior brain regions encom-
passes the core neuropathology in schizophrenia
[Andreasen et al., 1999; Friston, 1998]. This concept
recently gained backing from neuroimaging studies. For
example, although both the anterior cingulate and the cere-
bellum showed a task-specific relationship with the medial
superior frontal gyrus in healthy volunteers, this relation-
ship appears to be disrupted in schizophrenia [Honey
et al., 2005]. Furthermore, there was decreased functional
connectivity in schizophrenia during rest compared with
healthy controls, and such an abnormality was widely dis-
tributed throughout the entire brain [Liang et al., 2006].
In conclusion, decreased behavioral and neural sensitiv-
ity to bizarre facial expression may underlie disturbed
social behavior already in early stages of schizophrenia.
Our results strongly suggest that this abnormal processing
of facial expressions is not because of problems in face
processing per se in the FG. Rather inter-regional correla-
tion analysis points to decreased face-related coactivation
between the FG the amygdala and the PFC.
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